Appendix B: The Guideline Review Panel
The Guideline Review Panel is an independent panel that oversees the development of the guideline and takes responsibility for monitoring adherence to NICE guideline development processes. In particular, the panel ensures that stakeholder comments have been adequately considered and responded to. The panel includes members from the following perspectives: primary care, secondary care, lay, public health and industry.
Secondary care member
Clinical Governance and Prescribing Lead, North Tees PCT
Head of Medical Affairs, Novartis Pharmaceuticals UK